(Q45351891)

13 December 2017

title

Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples (English)

1 reference

13 December 2017

0 references

0 references

0 references

1 reference

1 reference

1

1 reference

13 December 2017

3

Göran Hallmans

1 reference

13 December 2017

Maria Nyström

2

1 reference

13 December 2017

Hans Stenlund

series ordinal

4

1 reference

13 December 2017

Göran Wadell

series ordinal

5

1 reference

13 December 2017

Peter Sundström

series ordinal

6

1 reference

13 December 2017

language of work or name

1 reference

2 April 2013

1 reference

Multiple Sclerosis Journal

13 December 2017

published in

1 reference

13 December 2017

volume

19

1 reference

13 December 2017

issue

12

1 reference

13 December 2017

page(s)

1587-1591

1 reference

Environmental risk factors for multiple sclerosis. Part I: The role of infection

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Multiple sclerosis and Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Epstein-Barr virus and multiple sclerosis: interaction with HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Vitamin D as a protective factor in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Relationship of UV exposure to prevalence of multiple sclerosis in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Calculating measures of biological interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Regulatory T cell activity in primary and persistent Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Environmental factors and their timing in adult-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Smoking as a risk factor for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Vitamin A and systemic inflammation as protective factors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513483888

21 January 2018

Identifiers

DOI

10.1177/1352458513483888

1 reference

13 December 2017

1 reference